The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Andreeva Yu.S.

Krasnov Research Institute of Eye Diseases

Alkharki L.

Krasnov Research Institute of Eye Diseases

Budzinskaya M.V.

Krasnov Research Institute of Eye Diseases

Changes in intraocular pressure and biometric parameters of the anterior segment of the eye after intravitreal injections

Authors:

Andreeva Yu.S., Alkharki L., Budzinskaya M.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2024;140(2‑2): 7‑15

Read: 1683 times


To cite this article:

Andreeva YuS, Alkharki L, Budzinskaya MV. Changes in intraocular pressure and biometric parameters of the anterior segment of the eye after intravitreal injections. Russian Annals of Ophthalmology. 2024;140(2‑2):7‑15. (In Russ.)
https://doi.org/10.17116/oftalma20241400227

Recommended articles:
Long-term outcomes of phakic intraocular lens implantation in high myopia. Russian Annals of Ophthalmology. 2025;(1):28-31
Modern devi­ces for microinvasive glaucoma surgery. Russian Annals of Ophthalmology. 2025;(5):101-108

References:

  1. Campell J, Bronskill S, Bell C, Paterson M, Whitehead M, Gill SS. Rapid. expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol. 2010;128:359-362. 
  2. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. MARINA Study Group. Ranibizumab for neovascular age related macular degeneration. N Engl J Med. 2006;355:1419-1431.
  3. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. ANCHOR Study Group. Ranibizumab versus verteporfirin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
  4. Budzinskaya MV, Plyukhova AA, Alkharki L. Modern trends in anti-VEGF therapy for age-related macular degeneration. Russian Annals of Ophthalmology = Vestnik oftal’mologii. 2023;139(3-2):46-50. (In Russ.). https://doi.org/10.17116/oftalma202313903246
  5. Falavarjani KG, QD Nguyen. Adverse events and complications associated with in-travitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27:787-894.  https://doi.org/10.1038/eye.2013.107
  6. Plyukhova AA, Budzinskaya MV, Starostin KM, Rejdak R, Bucolo C, Reibaldi M, Toro MD. Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): A systematic review and network meta-analysis of direct comparative studies. J Cl Med. 2020;9(5):522.  https://doi.org/10.3390/jcm9051522
  7. Hollands H, Wong J, Bruen R, et al. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42: 807-811.  https://doi.org/10.3129/i07-172
  8. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intra- ocular pressure changes immediately after intravitreal injec- tions of anti-vascular endothelial growth factor agents. Am J Ophthalmol. 2008;146:930-934.e931. https://doi.org/10.1016/j.ajo.2008.07.007
  9. Wen J, Cousins S, Schuman S, Allingham R. Dynamic changes of the anterior chamber angle produced by intravitreal anti-vascular growth factor injections. Retina. 2016;36(10):1874-1881. https://doi.org/10.1097/IAE.0000000000001018
  10. Wingard J, Darcie A, Houlihan N, Lin J, Gieser J. Incidence of glaucoma or ocular hypertension after repeated anti-vascular endothelial growth factor injections for macular degeneration. Clinical Ophthalmology. 2019;13:2563-2572. https://doi.org/10.1016/j.ajo.2004.04.054
  11. Alkin Z, Perente I, Altan C, et al. Changes in Anterior Segment Morphology after Intravitreal Injection of Bevacizumab and Bevacizumab — triamcinolone Acetate Combination. Eur J Ophthalmol. 2013;23(4):504-509.  https://doi.org/10.5301/ejo.5000241
  12. Alaghband P, Beltran-Agulló L, Galvis E, Overby D, Lim K. Effect of phacoemulsification on facility of outflow. Br J Ophthalmol. 2018;102(11):1520-1526. https://doi.org/10.1136/bjophthalmol-2017-311548
  13. Bakri SJ, Moshfeghi DM, Francom S, et al. Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age- related macular degeneration clinical trials. Ophthalmology. 2014;121:1102-1108. https://doi.org/10.1016/j.ophtha.2013.11.029
  14. Nolan P, See L, Friedman, David S, Chan, Yiong-Huak. Changes in Angle Configuration After Phacoemulsification Measured by Anterior Segment Optical Coherence Tomography. Journal of Glaucoma. 2008;17(6):455-459.  https://doi.org/10.1097/IJG.0b013e3181650f31
  15. Brown H., Zhong, Le, Whitman L., Lynch, Mary G.; Kilgo, Patrick D.; Hovis, Kristen L. Reduced intraocular pressure after cataract surgery in patients with narrow angles and chronic angle-closure glaucoma. J Cataract Refract Surg. 2014;40(10):1610-1614. https://doi.org/10.1016/j.jcrs.2014.01.038
  16. Poley BJ, Lindstrom RL, Samuelson TW. Longterm effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008;34:735-742.  https://doi.org/10.1016/j.jcrs.2007.12.045
  17. Barzanouni E, Idani D, Sharifipour F. In Vivo Intraocular Lens Thickness Measurement and Power Estimation Using Optical Coherence Tomography. J Ophthalmic Vis Res. 2022;17(3):353-359.  https://doi.org/10.18502/jovr.v17i3.11572
  18. Guler M, Capkin M, Simsek A, et al. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber. Curr Eye Res. 2014;39:989-993.  https://doi.org/10.3109/02713683.2014.888452

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.